Results Conference Call

23 July 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543064 Scrip Symbol: COHANCE Dear Sir/Madam, Sub: Schedule of Conference Call for Investors and Analysts With reference to the captioned subject, please find enclosed details of the conference call scheduled to be held on Wednesday, 5 August 2026 at 6:30 P.M. (IST) for Investors and Analysts to discuss the Unaudited Financial Results of the Company for the Quarter ended 30 June 2026 (Q1 FY27), which will be announced earlier on the same day. Kindly take the same on record. Thanking You. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary & Compliance Officer Cohance Lifesciences Limited’s Q1 FY27 Results Conference Call on Wednesday, August 05, 2026 at 6.30 pm IST The senior management of Cohance Lifesciences Ltd. will participate in a Conference Call for investors and analysts to be hosted by the Company on Wednesday, August 05, 2026, at 6.30 pm IST. The conference call will be initiated with a brief management discussion on the Q1 FY27 results to be declared earlier in the day followed by an interactive Question & Answer session. Details of the conference call are as follows: Time and date 6.30 pm IST on Wednesday, August 05, 2026 Conference dial-in Primary number +91 22 6280 1141 / +91 22 7115 8042 Singapore Toll Free Number 800 101 2045 Hong Kong Toll Free Number 800 964 448 USA Toll Free Number 1 866 746 2133 UK Toll Free Number 0 808 101 1573 To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Pre-registration You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use the passcode & pin to connect to call Please dial the above number 5-10 minutes prior to the scheduled start to ensure that you are connected to the call on time. For more information, please contact: Cyndrella Carvalho, Head - Investor Relations, Gavin Desa Cohance Lifesciences Limited CDR India Tel: 040 2354 3311 Tel: +91 98206 37649 Email: cyndrella.carvalho@cohance.com Email: gavin@cdr-india.com Q1 FY27 Concall Invite